We anticipate that the detailed molecular comprehension of immunogenicity of cancer cell death may open new strategies in cancer therapy. Heat-shock proteins (HSPs) are a family of chaperone ...

Hopefully this will contribute towards the development of new treatments that target the physical characteristics of cancer cells. The membranes of cancer cells are more pliant than the membranes ...

Immunotherapy, a type of treatment that activates a patient's immune system to target cancer cells, has been successful in many diseases but not ovarian cancer and it is unclear why. Checkpoint ...

"One of the deadliest and most remarkable characteristics of cancer cells is that regardless of where ... that Bcl-2 binds to the inositol 1,4,5-trisphosphate receptor (IP3R) channel and regulates ...

A study led by Massachusetts General Hospital (MGH) investigators reveals how spontaneous changes in the molecular characteristics ... circulating breast cancer cells, Nature (2016).

Ben-David explains: "In the nucleus of a healthy human cell, there are 23 pairs of chromosomes - half from the father and half from the mother, totaling 46. One of the characteristics of cancer ...

Immunotherapy has transformed cancer treatment in ... and patient survival." The five factors identified are: tumour mutational burden; effective T cell infiltration; the activity of transforming ...

Remarkably, Beethoven's Symphony No. 5 destroyed about 20% of cancer cells in just ... Both articles said that the cell lines in the experiments shared characteristics with epithelial cells ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

There are tens of trillions of cells ... can develop cancer at any age; the youngest known person with cancer was diagnosed as a newborn. A minority of cancer cases — only about 5% to 10% ...

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial. Sixty patients survived longer than 5 ...